Two of the vaccines we have for COVID-19 have the distinction of being the first mRNA vaccines to see widespread use in ...

The company, however, continues to work on a phase 1/2 study of its H5 mRNA flu vaccine for pandemic preparedness.

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

Here’s how it works. mRNA research enabled the remarkably fast production of COVID-19 vaccine candidates in the pandemic. But more broadly, the technology could revolutionize many areas of medicine ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at the University of Florida and the University of Texas MD Anderson Cancer ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. Cancer: it’s a diagnosis that most of us have learned to fear. On the one hand decades ...